A Multidisciplinary Approach to Fungal Infections: One-Year Experiences of a Center of Expertise in Mycology.
antifungal treatment
diagnosis
invasive fungal diseases
multidisciplinary
mycology
Journal
Journal of fungi (Basel, Switzerland)
ISSN: 2309-608X
Titre abrégé: J Fungi (Basel)
Pays: Switzerland
ID NLM: 101671827
Informations de publication
Date de publication:
10 Nov 2020
10 Nov 2020
Historique:
received:
14
10
2020
revised:
05
11
2020
accepted:
06
11
2020
entrez:
13
11
2020
pubmed:
14
11
2020
medline:
14
11
2020
Statut:
epublish
Résumé
Invasive fungal diseases (IFDs) often represent complicated infections in complex patient populations. The Center of Expertise in Mycology Radboudumc/CWZ (EMRC) organizes a biweekly multidisciplinary mycology meeting to discuss patients with severe fungal infections and to provide comprehensive advice regarding diagnosis and treatment. Here, we describe the patient population discussed at these meetings during a one-year period with regards to their past medical history, diagnosis, microbiological and other diagnostic test results and antifungal therapy. The majority of patients discussed were adults (83.1%), 62.5% of whom suffered from pulmonary infections or signs/symptoms, 10.9% from otorhinolaryngeal infections and/or oesophagitis, 9.4% from systemic infections and 9.4% from central nervous system infections. Among children, 53.8% had pulmonary infections or signs/symptoms, 23.1% systemic fungal infections and 23.1% other, miscellaneous fungal infections. 52.5% of adult patients with pulmonary infections/symptoms fulfilled diagnostic criteria for chronic pulmonary aspergillosis (CPA). Culture or polymerase chain reaction (PCR) demonstrated fungal pathogens in 81.8% of patients, most commonly
Identifiants
pubmed: 33182621
pii: jof6040274
doi: 10.3390/jof6040274
pmc: PMC7712561
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Lancet Respir Med. 2020 Jun;8(6):e48-e49
pubmed: 32445626
Am J Respir Crit Care Med. 2020 Jul 1;202(1):132-135
pubmed: 32396381
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38
pubmed: 29544767
J Infect. 2020 Jul;81(1):131-146
pubmed: 32330523
Emerg Infect Dis. 2015 Jun;21(6):1041-4
pubmed: 25988348
Science. 2018 May 18;360(6390):739-742
pubmed: 29773744
Eur Respir J. 2016 Jan;47(1):45-68
pubmed: 26699723
J Antimicrob Chemother. 2016 Nov;71(suppl 2):ii37-ii42
pubmed: 27880668
Am J Respir Crit Care Med. 2012 Jul 1;186(1):56-64
pubmed: 22517788
Clin Infect Dis. 2019 Apr 24;68(9):1463-1471
pubmed: 30307492
J Antimicrob Chemother. 2019 Sep 1;74(9):2759-2766
pubmed: 31236587
Intensive Care Med. 2012 Nov;38(11):1761-8
pubmed: 22895826
Clin Infect Dis. 2016 Aug 15;63(4):e1-e60
pubmed: 27365388
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
Emerg Infect Dis. 2019 Jan;25(1):176-178
pubmed: 30561296
Am J Respir Crit Care Med. 2017 Apr 7;196(4):524-527
pubmed: 28387526
J Infect Dis. 2020 Aug 5;222(Supplement_3):S175-S198
pubmed: 32756879
Mycoses. 2020 Jun;63(6):625-631
pubmed: 32297377
Clin Exp Allergy. 2013 Aug;43(8):850-73
pubmed: 23889240
BMC Public Health. 2019 May 17;19(1):591
pubmed: 31101036
Lancet Respir Med. 2018 Oct;6(10):782-792
pubmed: 30076119
Trends Microbiol. 2014 Mar;22(3):120-7
pubmed: 24530175
Eur Respir J. 2011 Apr;37(4):865-72
pubmed: 20595150
Clin Infect Dis. 2004 Aug 1;39(3):309-17
pubmed: 15306996
Mycoses. 2019 Sep;62(9):765-772
pubmed: 31162731
J Fungi (Basel). 2019 Jul 20;5(3):
pubmed: 31330862
J Fungi (Basel). 2017 Oct 18;3(4):
pubmed: 29371573